Trials / Completed
CompletedNCT02785744
Genzyme Osteopenia/Osteoporosis Study
Prevalence of Gaucher Among Patients With Osteopenia/Osteoporosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 76 (actual)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Gaucher disease is a most common genetic metabolic disease characterized by low platelet number, liver and spleen enlargement and various forms of bone diseases including low bone mineral density leading to brittle bones. Various treatment options are now available for this disease. The purpose of this research study is to determine the prevalence of Gaucher disease in patients with low bone mineral density as observed by DEXA scan, which is a form of X-Ray of the bone.
Detailed description
Gaucher disease is a potential secondary cause of low bone mineral density and it is prevalent among patients with low BMD. This cross sectional design study will measure point prevalence of Gaucher disease in patients with low bone mineral density (BMD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Gaucher disease DNA mutation analysis |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2019-09-01
- Completion
- 2019-09-01
- First posted
- 2016-05-30
- Last updated
- 2021-03-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02785744. Inclusion in this directory is not an endorsement.